Directory
>
Mohamed Ladha
Mohamed Ladha
President and General Manager, North America
Bridgewater Township, New Jersey, United States
Mohamed Ladha
Summary
Mohamed Ladha is a seasoned executive with over 23 years of experience in the pharmaceutical and biotechnology sectors, specializing in oncology, rare diseases, and specialty care. He has successfully commercialized and launched more than 13 products across diverse geographies, including the US, EU, and Japan. Mohamed has held high-level positions such as President and General Manager, where he oversaw significant P&L responsibilities, managing portfolios exceeding $500 million in annual revenue. His extensive expertise encompasses cross-functional team leadership, strategic planning, and market access, making him a pivotal figure in product commercialization. He is known for building and leading large teams and fostering collaboration among various stakeholders to achieve organizational goals. Mohamed's academic credentials include an MBA from Northwestern University and an MPA from Harvard Kennedy School, which complement his practical knowledge in managing complex business operations. His commitment to innovation and excellence has consistently resulted in superior outcomes in highly competitive markets.
Mohamed Ladha
Work Experience
President and General Manager, North America at
RECORDATI RARE DISEASES SPAIN SLU
April 2022 - Present
General Manager, Head of US Region Business Unit Operations-Hematology-Oncology at
Oncopeptides AB (publ)
September 2020 - March 2022
Senior Vice President and Head of US Commercial Organization Operations at
Oncopeptides AB (publ)
March 2020 - September 2020
CCO and Group Vice President, Commercial, Operations and Medical Affairs-Immuno-Oncology at
Tocagen Inc
September 2018 - March 2020
US Head, Lung Cancer Franchise Portfolio (ALUNBRIG and TAK-788) at
Takeda Oncology
February 2017 - September 2018
US and Global Head, Brigatinib & AP32788 Marketing at
Takeda Pharmaceuticals America, Inc.
November 2015 - February 2017
US GM Biologics & Global Biologics Marketing Head- Oncology, Immunology & Nephrology/Dialysis at
Pfizer, Inc.
June 2012 - November 2015
Global Oncology Marketing and LCM Leader at
Merck
November 2009 - June 2012
Specialty Commercial Development Team Leader (Oncology, ID, Immunology, GI, Vaccines, Neurology) at
Schering Plough Corporationmerck
May 2009 - November 2009
Oncology and Infectious Disease Commercial Development Leader (New Products Marketing) at
Schering Plough
January 2008 - November 2009
Oncology Global Marketing and Franchise Development Leader at
Schering Plough
January 2007 - January 2008
Oncology Sales at
Schering Plough
April 2004 - December 2006
Product Marketing-Oncology-Management Associate- Leadership Development Program at
Schering Plough
June 2003 - April 2004
New Products Development at
PFIZER PHARMACEUTICALS (HONGKONG) LIMITED
January 2002 - January 2002
New Products Development at
Vertex Pharmaceuticals
January 2001 - January 2001
Research-Cancer at
Dana-Farber Cancer Institute
June 1995 - September 2000
Research Assistant/Summer-Winter Intern at
Em Luse Center University of Vermont
May 1994 - May 1995
Mohamed Ladha
Education
Kellogg School of Management, Mba
January 2001 - January 2003
Harvard Kennedy School, Mpa
January 2000 - January 2003
Frequently Asked Questions about Mohamed Ladha
What is Mohamed Ladha email address?
Mohamed Ladha's primary email address is ******@recordatirarediseases.com. To view the full verified email and additional contact details, sign up for free with Muraena.
Where Mohamed Ladha graduated from?
Mohamed Ladha holds a degree in Marketing And Finance from Kellogg School of Management.
How can I directly contact Mohamed Ladha?
To contact Mohamed Ladha directly, you can use the email address ******@recordatirarediseases.com. Complete contact information is available upon registration with Muraena.
Who is Mohamed Ladha?
Mohamed Ladha is a seasoned executive with over 23 years of experience in the pharmaceutical and biotechnology sectors, specializing in oncology, rare diseases, and specialty care. He has successfully commercialized and launched more than 13 products across diverse geographies, including the US, EU, and Japan. Mohamed has held high-level positions such as President and General Manager, where he oversaw significant P&L responsibilities, managing portfolios exceeding $500 million in annual revenue. His extensive expertise encompasses cross-functional team leadership, strategic planning, and market access, making him a pivotal figure in product commercialization. He is known for building and leading large teams and fostering collaboration among various stakeholders to achieve organizational goals. Mohamed's academic credentials include an MBA from Northwestern University and an MPA from Harvard Kennedy School, which complement his practical knowledge in managing complex business operations. His commitment to innovation and excellence has consistently resulted in superior outcomes in highly competitive markets.
Mohamed`s contact details
******@recordatirarediseases.com
*************@oncopeptides.com